JPJay N. Patel

Jay N. Patel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jay N. Patel has a total of 96 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acute Sympathetic Blockade Improves Insulin‐Mediated Microvascular Blood Flow in the Forearm of Adult Human Subjects With Obesity

    by Emily C. Smith, Jay N. Patel, Amr Wahba, Andrew Cluckey, Jorge Celedonio, JinWoo Park, LaToya Hannah, Suzanna Lonce, Cyndya A. Shibao, Sachin Y. Paranjape, et al.

    Background: Obesity is associated with resistance to the metabolic (glucose uptake) and vascular (nitric‐oxide mediated dilation and microvascular recruitment) actions of insulin. These vascular effects contribute to insulin sensitivity by increasing tissue delivery of glucose. Studies by us and others suggest that sympathetic activation contributes to insulin resistance to glucose uptake. Here we tested the hypothesis that sympathetic activation contributes to impaired insulin‐mediated vasodilation in adult subjects with obesity. Methods and Results: In a randomized crossover study, we used a euglycemic hyperinsulinemic clamp in 12 subjects with obesity to induce forearm arterial vasodilation (forearm blood flow) and microvascular recruitment (contrast‐enhanced ultrasonography) during an intrabrachial infusion of saline (control) or phentolamine (sympathetic blockade). Insulin increased forearm blood flow on both study days (from 2.21±1.22 to 4.89±4.21 mL/100 mL per min, P =0.003 and from 2.42±0.89 to 7.19±3.35 mL/100 mL per min, P =0.002 for the intact and blocked day, respectively). Sympathetic blockade with phentolamine resulted in a significantly greater increase in microvascular flow velocity (∆microvascular flow velocity: 0.23±0.65 versus 2.51±3.01 arbitrary intensity units (AIU/s) for saline and phentolamine respectively, P =0.005), microvascular blood volume (∆microvascular blood volume: 1.69±2.45 versus 3.76±2.93 AIU, respectively, P =0.05), and microvascular blood flow (∆microvascular blood flow: 0.28±0.653 versus 2.51±3.01 AIU 2 /s, respectively, P =0.0161). To evaluate if this effect was not due to nonspecific vasodilation, we replicated the study in 6 subjects with obesity comparing intrabrachial infusion of phentolamine to sodium nitroprusside. At doses that produced similar increases in forearm blood flow, insulin‐induced changes in microvascular flow velocity were greater during phentolamine than sodium nitroprusside (%microvascular flow velocity=58% versus 29%, respectively, P =0.031). Conclusions: We conclude that sympathetic activation impairs insulin‐mediated microvascular recruitment in adult subjects with obesity.


  • Open Access

    Vascular Access Management in Complex Percutaneous Coronary Interventions

    by Jimmy Kerrigan, Timir K Paul, Jay Patel, Walid Saad, Andrew Morse, Elias Haddad, Angel Chandler, Jonathan Emling, Hady Lichaa

    Vascular access is a crucial step, which every interventional cardiologist needs to be skilled with to consistently achieve excellent periprocedural outcomes. Some operators argue that it is the most important aspect of the entire intervention. Hence, careful planning of vascular access in an individualized fashion – based on the patient’s clinical status, anatomy, and technical requirements of the intervention – is the first step in securing optimal procedural safety and successful results. We briefly review multiple aspects of vascular access and management including site selection, ultrasound guidance, micro-puncture techniques, sheathless techniques, limb perfusion, clinical monitoring, large bore closure, and management of complications. Approaching every vascular access in a systematic way, even in emergent situations, allows operators to minimize the risk of complications, especially in an often severely ill patient population.


  • Association of Depression and Cognitive Dysfunction With Patient-Centered Outcomes After Transcatheter Aortic Valve Replacement

    by Bassim El-Sabawi, Harrison Cloud, Jay N. Patel, Susan P. Bell, Sammy Elmariah, William F. Fearon, Juyong B. Kim, Robert N. Piana, Samir R. Kapadia, Dharam J. Kumbhani, et al.

    BACKGROUND:Depression and cognitive dysfunction (CD) are not routinely screened for in patients before transcatheter aortic valve replacement (TAVR) and their association with postprocedural outcomes is poorly understood. The objectives of this study are to determine the prevalence of depression and CD in patients with aortic stenosis undergoing TAVR and evaluate their association with mortality and quality of life. METHODS:We analyzed a prospective, multicenter TAVR registry that systematically screened patients for preexisting depression and CD with the Patient Health Questionnaire-2 and Mini-Cog, respectively. The associations with mortality were assessed with Cox proportional hazard models and quality of life (Kansas City Cardiomyopathy Questionnaire and EuroQol visual analogue scale) were evaluated using multivariable ordinal regression models. RESULTS:A total of 884 patients were included; median follow-up was 2.88 years (interquartile range=1.2-3.7). At baseline, depression was observed in 19.6% and CD in 31.8%. In separate models, after adjustment, depression (HR, 1.45 [95% CI, 1.13-1.86]; P<0.01) and CD (HR, 1.27 [95% CI, 1.02-1.59]; P=0.04) were each associated with increased mortality. Combining depression and CD into a single model, mortality was greatest among those with both depression and CD (n=62; HR, 2.06 [CI, 1.44-2.96]; P<0.01). After adjustment, depression was associated with 6.6 (0.3-13.6) points lower on the Kansas City Cardiomyopathy Questionnaire 1-year post-TAVR and 6.7 (0.5-12.7) points lower on the EuroQol visual analogue scale. CD was only associated with lower EuroQol visual analogue scale. CONCLUSIONS:Depression and CD are common in patients that undergo TAVR and are associated with increased mortality and worse quality of life. Depression may be a modifiable therapeutic target to improve outcomes after TAVR.


  • Open Access

    Metabolic Signatures of Cardiac Dysfunction, Multimorbidity, and Post–Transcatheter Aortic Valve Implantation Death

    by Andrew S. Perry, Shilin Zhao, Venkatesh Murthy, Deepak K. Gupta, William F. Fearon, Juyong B. Kim, Samir Kapadia, Dharam J. Kumbhani, Linda Gillam, Brian Whisenant, et al.

    Background: Studies in mice and small patient subsets implicate metabolic dysfunction in cardiac remodeling in aortic stenosis, but no large comprehensive studies of human metabolism in aortic stenosis with long‐term follow‐up and characterization currently exist. Methods and Results: Within a multicenter prospective cohort study, we used principal components analysis to summarize 12 echocardiographic measures of left ventricular structure and function pre–transcatheter aortic valve implantation in 519 subjects (derivation). We used least absolute shrinkage and selection operator regression across 221 metabolites to define metabolic signatures for each structural pattern and measured their relation to death and multimorbidity in the original cohort and up to 2 validation cohorts (N=543 for overall validation). In the derivation cohort (519 individuals; median age, 84 years, 45% women, 95% White individuals), we identified 3 axes of left ventricular remodeling, broadly specifying systolic function, diastolic function, and chamber volumes. Metabolite signatures of each axis specified both known and novel pathways in hypertrophy and cardiac dysfunction. Over a median of 3.1 years (205 deaths), a metabolite score for diastolic function was independently associated with post–transcatheter aortic valve implantation death (adjusted hazard ratio per 1 SD increase in score, 1.54 [95% CI, 1.25–1.90]; P <0.001), with similar effects in each validation cohort. This metabolite score of diastolic function was simultaneously associated with measures of multimorbidity, suggesting a metabolic link between cardiac and noncardiac state in aortic stenosis. Conclusions: Metabolite profiles of cardiac structure identify individuals at high risk for death following transcatheter aortic valve implantation and concurrent multimorbidity. These results call for efforts to address potentially reversible metabolic biology associated with risk to optimize post–transcatheter aortic valve implantation recovery, rehabilitation, and survival.


  • Open Access

    659 Optimising resources in a safe and effective neonatal murmur pathway to improve patient care

    by Joanna Longman, Jay Patel, Roshni Mansfield, Sundar Sathiyamurthy, Jayanta Banerjee

    Background Neonatal heart murmurs are commonly heard during routine newborn examination. In our institution, babies found to have a murmur on the postnatal ward are reviewed in a registrar-led murmur clinic, ideally within 10 days. If the murmur persists, they are referred for review in an echocardiography clinic led by a Neonatologist with Expertise in Cardiology. We have recently introduced a paediatric echo technician to the pathway who is available to perform two echocardiograms each week. Objectives We sought to assess the safety and efficacy of our neonatal murmur pathway. In addition, we evaluated whether the availability of the echo technician has reduced the echo waiting time. Methods Data including referral dates, clinic dates and outcomes were collected retrospectively from the electronic patient records of all babies seen in both murmur and echo clinic from September 2019 to August 2020. Results 265 babies were referred to the registrar-led murmur clinic. The median waiting time from referral to murmur clinic appointment was 13 days (IQR 9–17). The majority (68.8%) no longer had a murmur and were discharged from murmur clinic. 72 babies (27.1%) were referred to either the echo technician (29, 10.9%) or consultant echo clinic (43, 16.2%). Four babies (1.5%) were referred directly to cardiology from murmur clinic with concerning clinical findings. The median waiting time from murmur clinic to an echo was 43 days (IQR 19–93) overall; however amongst those who were seen by an echo technician the waiting time was 19 days (IQR 16.5–36). The overall waiting time has reduced from 48 days in a previous evaluation performed between April and December 2016. Of the 72 babies referred for an echo 44% were found to have pathology. 14 babies (19%) had an atrial septal defect, ventricular septal defect, patent ductus arteriosus or combinations of these. Two patients had pulmonary stenosis, one a bicuspid aortic valve and aortic stenosis and one had turbulent flow in the left pulmonary artery and aorta. The remainder had an isolated finding of a patent foramen ovale. No babies re-presented with signs or symptoms of congenital heart disease between discharge from postnatal ward and murmur clinic appointment or after discharge from the murmur clinic. Conclusions The provision of a registrar-led murmur clinic is a safe and effective screening tool for babies with a murmur. Following senior review all babies with murmur on the postnatal ward can therefore be safely discharged home in the first 24 hours after birth. In the absence of registrar availability, this screening clinic could be led by a general paediatrician or neonatologist. We have shown that this model can lead to a reduction in the number of babies requiring an echo by over two thirds. The introduction of echocardiography performed by the echo technician can further improve the waiting time for an echo. We aim to improve neonatal trainee awareness of details of the pathway to ensure babies are discharged early from the postnatal ward with murmur clinic follow up, and that the echo technician appointments are utilised appropriately.

  • Topical Tranexamic Acid in Total Knee Arthroplasty Patients with Increased Thromboembolic Risk

    by Jonathon Spanyer, Jay Patel, Eric Emberton, Langan S. Smith, Arthur L. Malkani

    The purpose of this study was to evaluate the efficacy and safety profiles of topical tranexamic acid (TXA) in patients undergoing elective total knee arthroplasty (TKA) with comorbid conditions precluding them from intravenous (IV) TXA use. A total of 104 patients were divided into two groups: 47 in the normal-risk group and 57 in the high-risk group, with the latter representing those with one or more risk factors for venous thromboembolism (VTE). Demographics were similar between groups, and there were no differences with regard to postoperative changes in hemoglobin (− 3.42 g/dL ± 1.07 and − 3.68 g/dL ± 1.07, p = 0.214), total drain output (630.2 mL ± 331.6 and 566.9 mL ± 343.9, p = 0.344), postoperative transfusion rate (2.1 and 3.5%, p = 0.675), or total number of complications 3 (6.5%) and 5 (8.8%) for the normal- and high-risk groups, respectively (p = 0.671). Topical TXA exhibited a similar safety and efficacy profile in reducing postoperative blood loss in a group of patients at increased thromboembolic risk, without a significant increase in complications or thromboembolic events. Topical TXA appears to represent a safe and efficacious alternative to IV TXA in patients at high risk for VTE undergoing TKA.


  • Comparison of Inhospital Outcomes and Hospitalization Costs of Peripheral Angioplasty and Endovascular Stenting

    by Sidakpal S. Panaich, Shilpkumar Arora, Nilay Patel, Nileshkumar J. Patel, Sopan Lahewala, Shantanu Solanki, Sohilkumar Manvar, Chirag Savani, Sunny Jhamnani, Vikas Singh, et al.


  • Comparison of Intravenous versus Topical Tranexamic Acid in Total Knee Arthroplasty: A Prospective Randomized Study

    by Jay N. Patel, Jonathon M. Spanyer, Langan S. Smith, Jiapeng Huang, Madhusudhan R. Yakkanti, Arthur L. Malkani


  • Characteristics of Sleep Disturbance in Patients with Carpal Tunnel Syndrome

    by Jay N. Patel, Steven J. McCabe, John Myers

    Background: Sleep disturbance is common in carpal tunnel syndrome (CTS), and we hypothesize that it has an important impact on the quality of life of CTS patients. The characteristic of sleep problems associated with CTS has not been evaluated. Methods: We performed a case-control study to measure the association between a variety of sleep disturbances and CTS. Sixty-two cases with clinically diagnosed CTS and a probable or classic hand diagram were compared to 138 primary care patients without CTS. In addition to demographic features, we collected the nature of sleep disturbance experienced by the patients from a categorical list and the nature, impact, and severity of sleep disturbance using the Insomnia Severity Index. Results: Patients with CTS complained of significantly more severe problems with sleep than the control population and had multiple sleep complaints compared to the control group. Sixty-three of the 138 control patients indicated that they had one cause of sleeping disturbance with no control patient choosing more than one. In contrast, in CTS patients, 44 of 63 patients indicated they had two or more causes of sleep disturbance. The Insomnia Severity Index was significantly higher in CTS patients and the impact of sleep disturbance on quality of life was higher in the cases. Conclusion: Sleep disturbance in CTS patients is characterized by a broad array of physical symptoms that have a significant impact on quality of life.